242 related articles for article (PubMed ID: 30653458)
1. Red blood cell alloimmunisation in transfusion-dependent thalassaemia: a systematic review.
Franchini M; Forni GL; Marano G; Cruciani M; Mengoli C; Pinto V; De Franceschi L; Venturelli D; Casale M; Amerini M; Capuzzo M; Grazzini G; Masiello F; Pati I; Veropalumbo E; Vaglio S; Pupella S; Liumbruno GM
Blood Transfus; 2019 Jan; 17(1):4-15. PubMed ID: 30653458
[TBL] [Abstract][Full Text] [Related]
2. Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan.
Zaidi U; Borhany M; Ansari S; Parveen S; Boota S; Shamim I; Zahid D; Shamsi T
Transfus Med; 2015 Apr; 25(2):106-10. PubMed ID: 25870030
[TBL] [Abstract][Full Text] [Related]
3. Maternal red blood cell alloimmunisation in south western Uganda.
Natukunda B; Mugyenyi G; Brand A; Schonewille H
Transfus Med; 2011 Aug; 21(4):262-6. PubMed ID: 21371143
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of alloimmunization against red cell antigens in sickle cell disease & thalassaemia major patients on regular red cell transfusion.
Jariwala K; Mishra K; Ghosh K
Indian J Med Res; 2019 Jan; 149(1):34-40. PubMed ID: 31115372
[TBL] [Abstract][Full Text] [Related]
5. Alloimmunisation in thalassaemics: a comparison between recipients of usual matched and partial better matched blood. An evaluation at a tertiary care centre in India.
Pujani M; Pahuja S; Dhingra B; Chandra J; Jain M
Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s100-4. PubMed ID: 23399366
[TBL] [Abstract][Full Text] [Related]
6. The effect of extended c, E and K matching in females under 45 years of age on the incidence of transfusion-induced red blood cell alloimmunisation.
Oud JA; Evers D; de Haas M; de Vooght KMK; van de Kerkhof D; Som N; Péquériaux NCV; Hudig F; Albersen A; van der Bom JG; Zwaginga JJ
Br J Haematol; 2021 Nov; 195(4):604-611. PubMed ID: 34346067
[TBL] [Abstract][Full Text] [Related]
7. Red blood cell alloimmunization in transfusion-dependent Egyptian patients with thalassemia in a limited donor exposure program.
el-Danasoury AS; Eissa DG; Abdo RM; Elalfy MS
Transfusion; 2012 Jan; 52(1):43-7. PubMed ID: 21745214
[TBL] [Abstract][Full Text] [Related]
8. Complete RH and Kell matching related to low alloimmunisation risk in sickle cell disease: prevalence and risk factors of alloimmunisation in a Spanish Tertiary Care National Reference Centre.
Regalado-Artamendi I; Pérez-Corral AM; García-Morín M; Cela E; Beléndez C; Bardón-Cancho EJ; Pérez-Rus G; Pérez-Sánchez I; Pascual C; Monsalvo S; Falero C; Díez-Martín JL; Anguita J
Blood Transfus; 2021 Jul; 19(4):292-299. PubMed ID: 33085598
[TBL] [Abstract][Full Text] [Related]
9. Association between HLA-DRB1*01 and HLA-DRB1*15 with alloimmunisation in transfusion-dependent patients with thalassaemia.
Ebrahimi M; Dayer D; Jalalifar MA; Keikhaei B; Tahan Nejad Asadi Z
Transfus Med; 2020 Aug; 30(4):275-280. PubMed ID: 32227529
[TBL] [Abstract][Full Text] [Related]
10. Relationship between maternal antibody type and antenatal course following intrauterine transfusion for red cell alloimmunisation.
Walsh CA; Russell N; McAuliffe FM; Higgins S; Mahony R; Carroll S; McParland P
Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):235-9. PubMed ID: 24075591
[TBL] [Abstract][Full Text] [Related]
11. Red blood cell alloimmunizations in thalassaemia patients with regular transfusion in China: A systematic review and meta-analysis.
Zhang X; Li Y; Yan B; Li X; Sun A; Gui S
Transfus Clin Biol; 2023 May; 30(2):256-262. PubMed ID: 36764573
[TBL] [Abstract][Full Text] [Related]
12. Predictors of red cell alloimmunization in multitransfused Egyptian patients with β-thalassemia.
Hussein E; Ahmed Eldesoukey N; Rihan A; Kamal A
Arch Pathol Lab Med; 2014 May; 138(5):684-8. PubMed ID: 24786127
[TBL] [Abstract][Full Text] [Related]
13. Red blood cell alloimmunisation after platelet transfusion (excluding ABO blood group system).
Moncharmont P
Transfus Clin Biol; 2020 Aug; 27(3):185-190. PubMed ID: 32544526
[TBL] [Abstract][Full Text] [Related]
14. The erythrocyte alloimmunisation in patients with sickle cell anaemia: a systematic review.
da Cunha Gomes EG; Machado LAF; de Oliveira LC; Neto JFN
Transfus Med; 2019 Jun; 29(3):149-161. PubMed ID: 29845661
[TBL] [Abstract][Full Text] [Related]
15. Red blood cell alloimmunisation among Chinese patients with β-thalassaemia major in Taiwan.
Chao YH; Wu KH; Lu JJ; Shih MC; Peng CT; Chang CW
Blood Transfus; 2013 Jan; 11(1):71-4. PubMed ID: 22790261
[TBL] [Abstract][Full Text] [Related]
16. Acquired red blood cell alloantibodies in transfused patients of 80 years or over: a 2008-2013 national haemovigilance survey.
Moncharmont P; Barday G; Py JY; Meyer F;
Blood Transfus; 2017 May; 15(3):254-258. PubMed ID: 27416567
[TBL] [Abstract][Full Text] [Related]
17. [Red blood cell immunization in haemoglobinopathie: about 84 cases].
Ben Amor I; Louati N; Khemekhem H; Dhieb A; Rekik H; Mdhaffar M; Gargouri J
Transfus Clin Biol; 2012 Dec; 19(6):345-52. PubMed ID: 23103424
[TBL] [Abstract][Full Text] [Related]
18. Red blood cell alloimmunisation after platelet transfusion: a 5-year study.
Moncharmont P; Barday G; Meyer F
Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s147-8. PubMed ID: 24120592
[No Abstract] [Full Text] [Related]
19. Challenging the dogma: Red blood cell-directed autoimmunity as risk factor for red blood cell alloimmunisation after blood transfusion.
Oud JA; de Haas M; de Vooght KMK; van de Kerkhof D; Som N; Péquériaux NCV; Hudig F; van der Bom JG; Evers D; Zwaginga JJ
Br J Haematol; 2024 May; 204(5):2103-2111. PubMed ID: 38494337
[TBL] [Abstract][Full Text] [Related]
20. The haemoglobinopathy survey: The reality of transfusion practice in sickle cell disease and thalassaemia in England.
Trompeter S; Estcourt L; Mora A; Wong E; Collett D; Bolton-Maggs P; Poles D; Deary A; Watt A
Transfus Med; 2020 Dec; 30(6):456-466. PubMed ID: 33103306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
